Future Directions of Flow Diverter Therapy

Albert Ho Yuen Chiu, Timothy John Phillips

Research output: Contribution to journalArticle

Abstract

The treatment of intracranial aneurysms has undergone a few very significant paradigm shifts in its history. Needless to say, microsurgery and surgical clipping served as the initial basis for successful treatment of these lesions. The pursuit of endovascular therapy subsequently arose from the desire to reduce the invasiveness of therapy. While the first breakthrough arose with Guido Guglielmi's invention of the detachable platinum coil, commercialized flow diverter therapy represents a disruptive therapy with a completely different paradigm for aneurysmal obliteration. This has not only altered the distribution of aneurysmal management strategies, but also opened the gateway to the treatment of previously inoperable lesions. With the basic flow diverter stent technology now considered an integral part of the neurointerventional armamentarium, we now consider what may lay in the future - including potential directions for research with regards to case selection; the location and type of aneurysms which may become routinely treatable; and modifications to the flow diverter, which may increase its utility and safety in terms of size, structural design, and surface modifications.

Original languageEnglish
Pages (from-to)S106-S116
JournalNeurosurgery
Volume86
Issue numberSupplement_1
DOIs
Publication statusPublished - 1 Jan 2020

Fingerprint

Microsurgery
Intracranial Aneurysm
Therapeutics
Platinum
Stents
Aneurysm
History
Technology
Safety
Direction compound
Research

Cite this

Chiu, Albert Ho Yuen ; Phillips, Timothy John. / Future Directions of Flow Diverter Therapy. In: Neurosurgery. 2020 ; Vol. 86, No. Supplement_1. pp. S106-S116.
@article{443830418b1047ff9c07de6bf2765123,
title = "Future Directions of Flow Diverter Therapy",
abstract = "The treatment of intracranial aneurysms has undergone a few very significant paradigm shifts in its history. Needless to say, microsurgery and surgical clipping served as the initial basis for successful treatment of these lesions. The pursuit of endovascular therapy subsequently arose from the desire to reduce the invasiveness of therapy. While the first breakthrough arose with Guido Guglielmi's invention of the detachable platinum coil, commercialized flow diverter therapy represents a disruptive therapy with a completely different paradigm for aneurysmal obliteration. This has not only altered the distribution of aneurysmal management strategies, but also opened the gateway to the treatment of previously inoperable lesions. With the basic flow diverter stent technology now considered an integral part of the neurointerventional armamentarium, we now consider what may lay in the future - including potential directions for research with regards to case selection; the location and type of aneurysms which may become routinely treatable; and modifications to the flow diverter, which may increase its utility and safety in terms of size, structural design, and surface modifications.",
author = "Chiu, {Albert Ho Yuen} and Phillips, {Timothy John}",
year = "2020",
month = "1",
day = "1",
doi = "10.1093/neuros/nyz343",
language = "English",
volume = "86",
pages = "S106--S116",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams & Wilkins",
number = "Supplement_1",

}

Chiu, AHY & Phillips, TJ 2020, 'Future Directions of Flow Diverter Therapy' Neurosurgery, vol. 86, no. Supplement_1, pp. S106-S116. https://doi.org/10.1093/neuros/nyz343

Future Directions of Flow Diverter Therapy. / Chiu, Albert Ho Yuen; Phillips, Timothy John.

In: Neurosurgery, Vol. 86, No. Supplement_1, 01.01.2020, p. S106-S116.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Future Directions of Flow Diverter Therapy

AU - Chiu, Albert Ho Yuen

AU - Phillips, Timothy John

PY - 2020/1/1

Y1 - 2020/1/1

N2 - The treatment of intracranial aneurysms has undergone a few very significant paradigm shifts in its history. Needless to say, microsurgery and surgical clipping served as the initial basis for successful treatment of these lesions. The pursuit of endovascular therapy subsequently arose from the desire to reduce the invasiveness of therapy. While the first breakthrough arose with Guido Guglielmi's invention of the detachable platinum coil, commercialized flow diverter therapy represents a disruptive therapy with a completely different paradigm for aneurysmal obliteration. This has not only altered the distribution of aneurysmal management strategies, but also opened the gateway to the treatment of previously inoperable lesions. With the basic flow diverter stent technology now considered an integral part of the neurointerventional armamentarium, we now consider what may lay in the future - including potential directions for research with regards to case selection; the location and type of aneurysms which may become routinely treatable; and modifications to the flow diverter, which may increase its utility and safety in terms of size, structural design, and surface modifications.

AB - The treatment of intracranial aneurysms has undergone a few very significant paradigm shifts in its history. Needless to say, microsurgery and surgical clipping served as the initial basis for successful treatment of these lesions. The pursuit of endovascular therapy subsequently arose from the desire to reduce the invasiveness of therapy. While the first breakthrough arose with Guido Guglielmi's invention of the detachable platinum coil, commercialized flow diverter therapy represents a disruptive therapy with a completely different paradigm for aneurysmal obliteration. This has not only altered the distribution of aneurysmal management strategies, but also opened the gateway to the treatment of previously inoperable lesions. With the basic flow diverter stent technology now considered an integral part of the neurointerventional armamentarium, we now consider what may lay in the future - including potential directions for research with regards to case selection; the location and type of aneurysms which may become routinely treatable; and modifications to the flow diverter, which may increase its utility and safety in terms of size, structural design, and surface modifications.

U2 - 10.1093/neuros/nyz343

DO - 10.1093/neuros/nyz343

M3 - Article

VL - 86

SP - S106-S116

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - Supplement_1

ER -